KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Minority Interest (2021 - 2025)

Elevance Health (ELV) has disclosed Minority Interest for 5 consecutive years, with $129.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Minority Interest rose 24.04% to $129.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $129.0 million, a 24.04% increase, with the full-year FY2024 number at $111.0 million, up 12.12% from a year prior.
  • Minority Interest was $129.0 million for Q3 2025 at Elevance Health, roughly flat from $129.0 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $129.0 million in Q2 2025 to a low of $52.0 million in Q3 2022.
  • A 5-year average of $92.4 million and a median of $102.0 million in 2024 define the central range for Minority Interest.
  • Peak YoY movement for Minority Interest: decreased 29.49% in 2022, then surged 123.08% in 2023.
  • Elevance Health's Minority Interest stood at $68.0 million in 2021, then rose by 27.94% to $87.0 million in 2022, then rose by 13.79% to $99.0 million in 2023, then grew by 12.12% to $111.0 million in 2024, then increased by 16.22% to $129.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Minority Interest are $129.0 million (Q3 2025), $129.0 million (Q2 2025), and $117.0 million (Q1 2025).